KineMed, Inc. is a commercial-stage company focused on applying its biomarker platform technology to drug development, prescription and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. The Company�s diagnostic biomarker tests, or biomarker tests, directly measure the biological processes that cause disease by revealing the flux, or rate of production and destruction. It is focused on applying its biomarker platform to three commercial areas: collaborations with corporate partners to develop drugs and other health-related products; sales of biomarker tests for non-prescription wellness management and for physicians to manage unmet medical needs, and opportunities to pair sales of drugs and nutraceuticals with its biomarker tests. The Company�s tests can be used to identify whether the effect of a drug candidate on a targeted biological process in an animal has a similar effect in humans.